| Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors T Duhen, R Duhen, R Montler, J Moses, T Moudgil, NF De Miranda, ... Nature communications 9 (1), 2724, 2018 | 839 | 2018 |
| The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC) EEW Cohen, RB Bell, CB Bifulco, B Burtness, ML Gillison, KJ Harrington, ... Journal for immunotherapy of cancer 7, 1-31, 2019 | 651 | 2019 |
| Neoantigen T-cell receptor gene therapy in pancreatic cancer R Leidner, N Sanjuan Silva, H Huang, D Sprott, C Zheng, YP Shih, ... New England Journal of Medicine 386 (22), 2112-2119, 2022 | 379 | 2022 |
| Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cells Z Zhang, S Kobayashi, AC Borczuk, RS Leidner, T LaFramboise, ... Carcinogenesis 31 (4), 577-586, 2010 | 226 | 2010 |
| Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard of autoimmunity at a distance MA Couey, RB Bell, AA Patel, MC Romba, MR Crittenden, BD Curti, ... Journal for immunotherapy of cancer 7, 1-11, 2019 | 204 | 2019 |
| Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome RS Leidner, DM Aboulafia AIDS Patient Care & STDs 19 (10), 635-644, 2005 | 196 | 2005 |
| Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT) A Marabelle, R Andtbacka, K Harrington, I Melero, R Leidner, T de Baere, ... Annals of Oncology 29 (11), 2163-2174, 2018 | 192 | 2018 |
| Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810 GS Falchook, R Leidner, E Stankevich, B Piening, C Bifulco, I Lowy, ... Journal for immunotherapy of cancer 4, 1-5, 2016 | 175 | 2016 |
| Multiparametric immune profiling in HPV–oral squamous cell cancer Z Feng, D Bethmann, M Kappler, C Ballesteros-Merino, A Eckert, RB Bell, ... JCI insight 2 (14), e93652, 2017 | 169 | 2017 |
| Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial RL Ferris, WC Spanos, R Leidner, A Gonçalves, UM Martens, C Kyi, ... Journal for immunotherapy of cancer 9 (6), e002568, 2021 | 157 | 2021 |
| OX40, PD‐1 and CTLA‐4 are selectively expressed on tumor‐infiltrating T cells in head and neck cancer R Montler, RB Bell, C Thalhofer, R Leidner, Z Feng, BA Fox, AC Cheng, ... Clinical & translational immunology 5 (4), e70, 2016 | 157 | 2016 |
| Dampening enthusiasm for circulating microRNA in breast cancer RS Leidner, L Li, CL Thompson PloS one 8 (3), e57841, 2013 | 141 | 2013 |
| Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells R Duhen, C Ballesteros-Merino, AK Frye, E Tran, V Rajamanickam, ... Nature communications 12 (1), 1047, 2021 | 137 | 2021 |
| Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell … R Leidner, M Crittenden, K Young, H Xiao, Y Wu, MA Couey, AA Patel, ... Journal for immunotherapy of cancer 9 (5), e002485, 2021 | 122 | 2021 |
| Safety and efficacy of durvalumab and tremelimumab alone or in combination in patients with advanced gastric and gastroesophageal junction adenocarcinoma RJ Kelly, J Lee, YJ Bang, K Almhanna, M Blum-Murphy, DVT Catenacci, ... Clinical Cancer Research 26 (4), 846-854, 2020 | 119 | 2020 |
| The microRNAs, MiR‐31 and MiR‐375, as candidate markers in Barrett's esophageal carcinogenesis RS Leidner, L Ravi, P Leahy, Y Chen, B Bednarchik, M Streppel, M Canto, ... Genes, Chromosomes and Cancer 51 (5), 473-479, 2012 | 111 | 2012 |
| Genetic Abnormalities of the EGFR Pathway in African American Patients With Non–Small-Cell Lung Cancer RS Leidner, P Fu, B Clifford, A Hamdan, C Jin, R Eisenberg, TJ Boggon, ... Journal of Clinical Oncology 27 (33), 5620-5626, 2009 | 106 | 2009 |
| Aberrantly methylated PKP1 in the progression of Barrett's esophagus to esophageal adenocarcinoma AM Kaz, Y Luo, S Dzieciatkowski, A Chak, JE Willis, MP Upton, ... Genes, Chromosomes and Cancer 51 (4), 384-393, 2012 | 94 | 2012 |
| Immunotherapy for head and neck cancer F Sim, R Leidner, RB Bell Hematology/Oncology Clinics 33 (2), 301-321, 2019 | 84 | 2019 |
| First-in-human study of cemiplimab alone or in combination with radiotherapy and/or low-dose cyclophosphamide in patients with advanced malignancies KP Papadopoulos, ML Johnson, AC Lockhart, K Moore, GS Falchook, ... Clinical Cancer Research 26 (5), 1025-1033, 2020 | 70 | 2020 |
